BRK-B vs ICMB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
ICMB exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a technical trend of 0/100. While the stock trades at a deep discount to book value (P/B 0.40), this is likely a value trap given the negative ROE (-12.74%) and a catastrophic Q/Q revenue decline of -1331.16%. The dividend yield of 30.23% is fundamentally unsustainable with a payout ratio of 160%, indicating the company is returning more capital than it earns. Consistent earnings misses (0/4 in the last year) further signal a deteriorating operational trajectory.
Compare Another Pair
Related Comparisons
BRK-B vs ICMB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Investcorp Credit Management BDC, Inc. (ICMB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.